✓ Last verified: February 24, 2026 — Edited & verified by Angelica Bottaro for HealingMaps Editorial Staff
Known For: The Buffalo psychiatrist who delivered Western New York’s first Spravato treatment — Dr. Jarod Masci’s Landmark Health Systems is a SPRAVATO REMS-certified center offering esketamine and TMS within a full outpatient psychiatric practice in Buffalo’s historic Allentown District.
| Review Scores | SPRAVATO REMS-certified center in Buffalo’s historic Allentown District; delivered WNY’s first Spravato treatment |
| Location | Buffalo, NY |
| Address | 387 Franklin Street, Buffalo, NY 14202 |
| Phone | (716) 462-0284 |
| Website | jarodmascimd.com |
| Treatments | Spravato (Esketamine) Nasal Spray, Transcranial Magnetic Stimulation (TMS), Psychiatry, Medication Management, Counseling |
| Conditions Treated | Treatment-Resistant Depression, Major Depressive Disorder, Acute Suicidal Ideation |
| Cost | Contact for pricing |
| Insurance | Insurance accepted; contact for verification |
| Clinical Lead | Dr. Jarod Masci, MD — Board-certified psychiatrist; administered Spravato to first Western New York patient |
💡 No clinic-specific pricing posted? See our ketamine therapy cost guide for typical pricing ranges by treatment type and insurance pathways.
HealingMaps Take: Landmark Health Systems holds a specific historical distinction in the Western New York psychiatric market: Dr. Jarod Masci administered the first Spravato treatment to a WNY patient, marking the region’s entry into FDA-approved esketamine therapy. That early-adopter status translates into nearly a decade of refined clinical protocols, insurance navigation expertise, and REMS compliance experience that newer Spravato providers cannot match. The 387 Franklin Street location in Buffalo’s historic Allentown District is walkable from downtown Buffalo and serves patients across the greater Buffalo metro including Amherst, Williamsville, Orchard Park, and West Seneca. Offering both Spravato AND Transcranial Magnetic Stimulation (TMS) provides modality flexibility — patients who don’t respond to one treatment can pivot to the other without switching clinics. The broader practice suite (psychiatry, medication management, counseling) means Spravato is delivered within a full mental health medical home rather than as a standalone service, which matters clinically because esketamine works best when combined with ongoing psychiatric care. Extended hours including Saturdays 9-3 accommodate working patients who can’t take time off during the week for twice-weekly induction sessions. For Buffalo patients with treatment-resistant depression who want the most experienced Spravato provider in Western New York, Landmark Health Systems is the clear clinical anchor.
Market Position: Landmark Health Systems is a Spravato-certified clinic in the Buffalo metro. Spravato (esketamine) is the FDA-approved ketamine treatment that most commercial insurance plans cover after prior authorization — unlike cash-pay IV ketamine.
Industry pricing reference. Landmark Health Systems has not published specific per-session pricing — contact the clinic directly for a quote. The calculator above shows typical metro-level cost estimates across protocols, not this clinic’s specific prices.
| Protocol | Typical Industry Cost | Offered Here |
|---|---|---|
| IV Ketamine | $350–$650/session | — |
| Spravato (esketamine) | $0–$250 copay (insured) | ✓ Yes |
| IM Ketamine | $250–$400/injection | — |
| KAP (with therapist) | $400–$1,200/session | — |
| At-home troches | $150–$300/month | — |
This 2-question summary is matched to the protocols and conditions Landmark Health Systems treats. Editorial responses are HealingMaps-authored, grounded in our 2026 Ketamine Clinic Intelligence Report.
Yes — Landmark Health Systems offers Spravato, which means they’re FDA REMS-certified and maintain the required two-hour in-office monitoring window after each dose. Spravato is the primary insurance-covered ketamine option for treatment-resistant depression. Worth confirming the prior-authorization timeline before booking your first session.
Landmark Health Systems treats depression via Spravato (FDA-approved for TRD). The Spravato pathway is the most likely to obtain commercial insurance coverage. TRD is typically defined as two or more prior antidepressant trials without sufficient response — patients meeting that bar are best candidates here.
Leave a Reply